| Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece C Avgerinou, I Giannezi, S Theodoropoulou, V Lazaris, G Kolliopoulou, ... Hematology 22 (7), 419-429, 2017 | 32 | 2017 |
| The β-globin Replicator greatly enhances the potential of S/MAR based episomal vectors for gene transfer into human haematopoietic progenitor cells EF Stavrou, VM Lazaris, A Giannakopoulos, E Papapetrou, A Spyridonidis, ... Scientific Reports 7 (1), 40673, 2017 | 18 | 2017 |
| The lipoprotein transport system in the pathogenesis of multiple myeloma: advances and challenges V Lazaris, A Hatziri, A Symeonidis, KE Kypreos Frontiers in Oncology 11, 638288, 2021 | 11 | 2021 |
| A multicenter cross-sectional study of the quality of life and iron chelation treatment satisfaction of patients with transfusion-dependent β-thalassemia, in routine care … V Goulas, A Kouraklis-Symeonidis, K Manousou, V Lazaris, G Pairas, ... Quality of Life Research 30, 467-477, 2021 | 8 | 2021 |
| A Cross-Sectional, Multicentric, Disease-Specific, Health-Related Quality of Life Study in Greek Transfusion Dependent Thalassemia Patients P Klonizakis, N Roy, I Papatsouma, M Mainou, I Christodoulou, ... Healthcare 12 (5), 524, 2024 | 6 | 2024 |
| Real-world data on the use of luspatercept in Greek patients with transfusion dependent thalassemia P Delaporta, A Kourakli, S Delicou, MD Diamantidis, C Kalkana, ... Blood 140 (Supplement 1), 8205-8207, 2022 | 6 | 2022 |
| Allogeneic hematopoietic stem cell transplantation for mixed or overlap myelodysplastic/myeloproliferative disorders A Symeonidis, S Chondropoulos, E Verigou, V Lazaris, A Kourakli, ... Frontiers in Oncology 12, 884723, 2022 | 6 | 2022 |
| Predictors of mortality for KPC-producing Klebsiella pneumoniae bloodstream infections in adult neutropenic patients with haematological malignancies SF Assimakopoulos, V Lazaris, M Papadimitriou-Olivgeris, M Lagadinou, ... Infectious Diseases 52 (6), 446-449, 2020 | 5 | 2020 |
| Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response S Siamoglou, R Boers, M Koromina, J Boers, A Tsironi, T Chatzilygeroudi, ... Human Genomics 17 (1), 37, 2023 | 4 | 2023 |
| Hepatitis C virus infection, but not hepatic iron overload is the dominant risk factor for the manifestation of hepatocellular carcinoma among Greek thalassemic patients A Kourakli, MD Diamantidis, ME Skafidas, S Delicou, D Pantelidou, ... Blood 132, 2347, 2018 | 4 | 2018 |
| High Frequency of Post-Transfusion Microchimerism Among Multi-Transfused Beta-Thalassemic Patients S Matsagos, E Verigou, A Kourakli, S Alexis, S Vrakas, C Argyropoulou, ... Frontiers in Medicine 9, 845490, 2022 | 3 | 2022 |
| Myelodysplastic neoplasm with isolated thrombocytopenia and immune thrombocytopenic purpura in adults: insights from a comparison of two national registries K Liapis, V Papadopoulos, C Pontikoglou, G Vrachiolias, E Stavroulaki, ... Leukemia 37 (3), 708-711, 2023 | 2 | 2023 |
| Choroidal thickness evaluation in a transfusion-dependent beta-thalassemia Greek population F Tsapardoni, OE Makri, V Lazaris, V Labropoulou, S Lygeros, ... Clinical Ophthalmology, 4511-4518, 2020 | 2 | 2020 |
| Sickle-cell disease in Greece: patient reported outcomes related to clinical complications, treatment choices and attitudes, beliefs and trends affecting potential … S Delicou, MD Diamantidis, K Manganas, E Eftychiadis, D Pantelidou, ... Blood 134, 4838, 2019 | 2 | 2019 |
| Non-Viral Episomal Vector Mediates Efficient Gene Transfer of the β-Globin Gene into K562 and Human Haematopoietic Progenitor Cells VM Lazaris, E Simantirakis, EF Stavrou, M Verras, A Sgourou, ... Genes 14 (9), 1774, 2023 | 1 | 2023 |
| Lipid and lipoprotein profile of patients with multiple myeloma before and after first-line treatment A Hatziri, V Lazaris, A Symeonidis, KE Kypreos Atherosclerosis 331, e125, 2021 | 1 | 2021 |
| Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification era E Verigou, T Chatzilygeroudi, V Lazaris, AL de Lastic, A Symeonidis Frontiers in Oncology 14, 1447001, 2024 | | 2024 |
| P1506: REAL-WORLD DATA ON THE USE OF LUSPATERCEPT IN GREEK PATIENTS WITH TRANSFUSION DEPENDENT THALASSEMIA P Delaporta, S Delicou, A Kouraklis-Symeonidis, M Diamantidis, ... HemaSphere 6, 1387-1388, 2022 | | 2022 |
| Assessment of HDL functionality in newly diagnosed multiple myeloma patients A Hatziri, V Lazaris, A Symeonidis, KE Kypreos Atherosclerosis 315, e150, 2020 | | 2020 |
| Acute chest syndrome in sickle cell disease. A brief review V Lazaris Achaiki Iatriki, 130, 2020 | | 2020 |
